Shares of Applied Genetic Technologies Corp. (AGTC) have returned nearly 49 percent over the last one month as the Company gears up to report additional results from X-linked retinitis pigmentosa (XLRP) and achromatopsia trial results this month.
from RTT - Biotech https://ift.tt/37RP1QJ
via IFTTT
No comments:
Post a Comment